Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Neoplasm Metastasis 8Brain Neoplasms 5Prostatic Neoplasms 4Recurrence 2Oligodendroglioma 2Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Venous Thromboembolism 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Liposarcoma 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Ependymoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Oxaliplatin 14Cetuximab 11Leucovorin 9Fluorouracil 9Magnetic Resonance Spectroscopy 8Nivolumab 7pembrolizumab 6Capecitabine 6encorafenib 5Irinotecan 5Bevacizumab 5dehydroftorafur 4Specimen Handling 4adagrasib 3Immunoglobulin G 3Disulfides 3Biopsy 3selpercatinib 2durvalumab 2cemiplimab 2X-Rays 2Watchful Waiting 2Standard of Care 2Radiotherapy 2Panitumumab 2Observation 2Ipilimumab 2Injections 2Gemcitabine 2Folfox protocol 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Colonic Neoplasms × abemaciclib × Clear all
NCT04616183 2025-12-23

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡